Wealth Science Advisors LLC Buys New Holdings in Equifax, Inc. $EFX

Wealth Science Advisors LLC bought a new stake in Equifax, Inc. (NYSE:EFX) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 16,400 shares of the credit services provider’s stock, valued at approximately $3,558,000. Equifax makes up approximately 2.1% of Wealth Science Advisors LLC’s holdings, making the stock its 10th largest holding.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Chicago Partners Investment Group LLC increased its holdings in Equifax by 142.3% during the 4th quarter. Chicago Partners Investment Group LLC now owns 2,787 shares of the credit services provider’s stock worth $584,000 after purchasing an additional 1,637 shares in the last quarter. Optas LLC bought a new stake in Equifax during the 4th quarter worth approximately $381,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Equifax by 0.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 54,581 shares of the credit services provider’s stock worth $11,843,000 after purchasing an additional 211 shares in the last quarter. Krilogy Financial LLC bought a new stake in Equifax during the 4th quarter worth approximately $212,000. Finally, Lecap Asset Management Ltd. bought a new stake in Equifax during the 4th quarter worth approximately $791,000. 96.20% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. Barclays decreased their price objective on Equifax from $240.00 to $215.00 and set an “equal weight” rating for the company in a report on Thursday, February 5th. Mizuho assumed coverage on Equifax in a report on Thursday, April 16th. They set an “outperform” rating and a $222.00 price objective for the company. Stifel Nicolaus decreased their price objective on Equifax from $253.00 to $235.00 and set a “buy” rating for the company in a report on Thursday, February 5th. BMO Capital Markets set a $195.00 price objective on Equifax in a report on Thursday, February 5th. Finally, Wells Fargo & Company decreased their price objective on Equifax from $240.00 to $230.00 and set an “overweight” rating for the company in a report on Wednesday. Thirteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $231.00.

Insiders Place Their Bets

In other news, EVP Jamil Farshchi sold 6,213 shares of Equifax stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $195.81, for a total value of $1,216,567.53. Following the completion of the transaction, the executive vice president owned 41,036 shares in the company, valued at $8,035,259.16. This trade represents a 13.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Mark W. Begor sold 37,791 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $201.89, for a total transaction of $7,629,624.99. Following the completion of the sale, the chief executive officer directly owned 230,506 shares in the company, valued at approximately $46,536,856.34. This trade represents a 14.09% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 49,671 shares of company stock worth $9,960,181 over the last quarter. 1.70% of the stock is currently owned by company insiders.

Equifax Price Performance

Shares of NYSE EFX opened at $174.71 on Friday. The company has a current ratio of 0.61, a quick ratio of 0.60 and a debt-to-equity ratio of 0.89. The stock has a fifty day simple moving average of $188.80 and a two-hundred day simple moving average of $205.61. Equifax, Inc. has a 1-year low of $166.02 and a 1-year high of $281.03. The firm has a market cap of $20.80 billion, a price-to-earnings ratio of 30.76, a price-to-earnings-growth ratio of 1.37 and a beta of 1.56.

Equifax (NYSE:EFX) last issued its earnings results on Tuesday, April 21st. The credit services provider reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.17. Equifax had a return on equity of 20.41% and a net margin of 11.12%.The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same period in the previous year, the company posted $1.53 earnings per share. The business’s revenue was up 14.3% on a year-over-year basis. Equifax has set its Q2 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.340-8.740 EPS. Analysts anticipate that Equifax, Inc. will post 8.57 earnings per share for the current year.

Equifax Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a dividend of $0.56 per share. This represents a $2.24 annualized dividend and a yield of 1.3%. This is a boost from Equifax’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Monday, March 9th. Equifax’s payout ratio is currently 39.44%.

Equifax Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.